Telephone sharing button Contact Us linkedin sharing button LinkedIn mailbox sharing button wuxivaccines@wuxibiologics.com
arrow_left sharing button
arrow_right sharing button

Accelerating Recombinant Protein Vaccine Development

Accelerating Recombinant Protein Vaccine Development WuXi Vaccines describes technologies that hasten the progress from vaccine discovery to commercialization By Jason He, PhD January 10, 2024 More automated processes can give scientists access to high-throughput...

Increasing Vaccine Efficacy with Novel Adjuvants

Increasing Vaccine Efficacy with Novel Adjuvants WuXi Vaccines describes how vaccine adjuvants can help shape immunological responses By Xinhao Ye, PhD, and Hongbing Wu September 10, 2024 WuXi Vaccines, a subsidiary of WuXi Biologics, is a leading contract development...

Preparing for the Next Pandemic

Preparing for the Next Pandemic By Jian Dong May 3, 2023 WuXi Vaccines maintains that if we are to be prepared for the next global health emergency, we must forge links that strengthen supply chains. To do its part,WuXi Vaccines has partnered with global...
Notice:

You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?